New injection aims to tackle stubborn high cholesterol
NCT ID NCT07278830
Summary
This study tested whether adding a new injectable drug called SAL003 to standard cholesterol pills (atorvastatin) could better lower 'bad' cholesterol (LDL-C) in adults with high cholesterol. It involved 214 participants and compared the effects of the new injection to a placebo over 24 weeks. The goal was to see if this combination is safe and more effective than the standard pill alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University，Guangzhou，Guangdong，510120
Guangzhou, Guangdong, 510120, China
Conditions
Explore the condition pages connected to this study.